ARCHIVES

Executive Summary of Centers, SPOREs Report

This article is from The Cancer Letter archive.

Vol. 29 No. 09 | February 28, 2003

Download PDF Visit The Full Archive

Related Articles

Survey Commissioned By Cancer Control Program Finds Important RMP Effort Being Phased Out

July 19, 1974

New: Special Reports on the Dialogue and NCI’s 2015 goal posted at cancerletter.com.

August 8, 2003

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

May 25, 2001

Budge Act Includes Language On Coverage Of Oral Cancer Drugs

August 13, 1993

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

Clearinghouse Finds Five Compounds Pose Risk To Humans

March 2, 1979